Mohan, H., Lenis, M. G., Laurette, E. Y., Tejada, O., Sanghvi, T., Leung, K., . . . Serghides, L. (2020). Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels. EBioMedicine.
Chicago-stil citatMohan, Haneesha, et al. "Dolutegravir in Pregnant Mice Is Associated With Increased Rates of Fetal Defects At Therapeutic but Not At Supratherapeutic Levels." EBioMedicine 2020.
MLA-referensMohan, Haneesha, et al. "Dolutegravir in Pregnant Mice Is Associated With Increased Rates of Fetal Defects At Therapeutic but Not At Supratherapeutic Levels." EBioMedicine 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.